Linezolid Sandoz Ltd (Linezolid)

Linezolid is an antibiotic that targets serious Gram‑positive bacterial infections.

• Skin and soft‑tissue infections: effective against MRSA and other resistant organisms.
• Hospital‑acquired pneumonia: used when standard therapy is ineffective.
• Complicated urinary tract infections: treats infections caused by resistant Gram‑positive pathogens.

• Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing the formation of the initiation complex and thereby halting translation. This action is bacteriostatic against most susceptible organisms and bactericidal at higher concentrations.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Metallic taste: altered taste perception.
• Myelosuppression: reduction in blood cell counts, usually reversible.

Serious or Rare Side Effects

• Peripheral neuropathy: sensory changes that may be irreversible.
• Optic neuropathy: visual disturbances requiring prompt evaluation.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Severe hypotension: rare but potentially life‑threatening.
• Lactic acidosis: metabolic disturbance needing urgent care.

Before prescribing Linezolid, consider the following safety measures.

• Monitor blood counts: watch for anemia, leukopenia, or thrombocytopenia.
• Assess renal and hepatic function: adjust use in severe impairment.
• Avoid serotonergic drugs: risk of serotonin syndrome.
• Caution in patients with a history of neuropathy: may exacerbate symptoms.
• Pregnancy and lactation: use only if clearly needed, after risk‑benefit assessment.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Linezolid interacts with several medication classes; awareness helps prevent adverse events.

Major Interactions (Avoid)

• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: may precipitate serotonin syndrome.
• Monoamine oxidase inhibitors (MAOIs): increase risk of hypertensive crisis.

Moderate Interactions (Monitor Closely)

• Rifampicin: may reduce linezolid plasma concentrations.
• Warfarin: potential alteration of anticoagulant effect, monitor INR.
• Ethanol: may enhance central nervous system depression.
• NSAIDs: increased risk of bleeding when combined with anticoagulants.
• Oral contraceptives: possible reduction in efficacy, advise additional contraception.